Detailed answers about NANOLIPO CANCER SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was NANOLIPO CANCER SOLUTIONS LIMITED founded?
NANOLIPO CANCER SOLUTIONS LIMITED was officially incorporated on 20 October 2025 and is registered under company number 16795773. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NANOLIPO CANCER SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NANOLIPO CANCER SOLUTIONS LIMITED?
NANOLIPO CANCER SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NANOLIPO CANCER SOLUTIONS LIMITED do?
NANOLIPO CANCER SOLUTIONS LIMITED operates in the following sectors: 21200 - Manufacture of pharmaceutical preparations, 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is NANOLIPO CANCER SOLUTIONS LIMITED's registered address?
The registered office address of NANOLIPO CANCER SOLUTIONS LIMITED is 45 UPPER REDLANDS ROAD, READING, ENGLAND, RG1 5JE. This is the official address filed with Companies House for legal and statutory correspondence.
Is NANOLIPO CANCER SOLUTIONS LIMITED financially stable?
Financial accounts for NANOLIPO CANCER SOLUTIONS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.